WHWK Whitehawk Therapeutics, Inc.
Price Chart
Executive Summary
Whitehawk Therapeutics announced an $87.5M PIPE financing, selling 4,330,866 shares at $3.92/share and 17,991,021 pre-funded warrants at $3.9199/warrant. The proceeds will extend the cash runway into H2 2028, but the massive dilution (~22.3M new shares vs. ~49.5M pre-deal) is severely bearish for existing shareholders. The $39.75M insider participation and 60-day lock-up provide some signal alignment, but the core event is a deeply dilutive capital raise at a ~$194M market cap.
Key Financial Metrics
Actionable Insight
The massive dilution (~45% of pre-deal shares outstanding) will pressure the stock. Watch for the closing on May 14 and any subsequent trading volume as the registration statement is filed. The insider participation and lock-up provide some near-term support, but the fundamental signal is a distressed capital raise. Consider short-term bearish positioning.
Key Facts
- Total gross proceeds of $87.5 million from PIPE financing
- 4,330,866 shares of common stock sold at $3.92 per share
- 17,991,021 pre-funded warrants sold at $3.9199 per warrant, exercisable at $0.0001 per share
- Insiders (executives, directors, affiliated funds) committed $39.75 million of the total
- Proceeds expected to extend cash runway into second half of 2028
- 60-day lock-up agreements for executive officers and directors
- Closing expected May 14, 2026, subject to customary conditions
- Registration rights agreement to be filed within 30 days of closing
Financial Impact
$87.5 million gross proceeds; dilution of approximately 22.3 million new shares (common + warrant shares) against a pre-deal market cap of ~$194M
Risk Factors
- Severe dilution to existing shareholders from 22.3 million new shares
- Potential for further price decline as the market absorbs the offering
- Clinical-stage biotech with no approved products; cash burn continues
- Risk that the PIPE does not close if conditions are not met
Market Snapshot
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-220656 |
| Document: d854431dex102.htm | 0001193125-26-220656 |
| Document: d854431dex41.htm | 0001193125-26-220656 |
| Document: d854431d8k.htm | 0001193125-26-220656 |
| Document: d854431dex991.htm | 0001193125-26-220656 |
| Document: 0001193125-26-220656-index-headers.html | 0001193125-26-220656 |
| Document: 0001193125-26-220656-index.html | 0001193125-26-220656 |
| Document: 0001193125-26-220656.txt | 0001193125-26-220656 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
5d ago
|
EFFECT
| $4.23 awaiting T+5 | awaiting T+5 | — | $4.16 (+1.65%) |
|
May 29, 2026
16d ago
|
S-3
| $4.49 $4.15 | ▲ +7.57% | ▲ +4.82% | $4.16 (+7.35%) |
|
May 13, 2026
4w ago
|
8-K
| $4.93 $4.07 | ▲ +17.44% | ▲ +16.29% | $4.16 (+15.62%) |
|
May 7, 2026
5w ago
|
8-K
| $3.94 $4.93 | ▲ +25.13% | ▲ +23.62% | $4.16 (+5.58%) |
|
Apr 9, 2026
9w ago
|
Insider Cluster
| $3.55 $4.23 | ▼ −19.15% | ▼ −15.97% | $4.16 (−17.18%) |
|
Apr 9, 2026
9w ago
|
Insider Cluster
| $3.55 $4.23 | ▼ −19.15% | ▼ −15.97% | $4.16 (−17.18%) |
|
Apr 9, 2026
9w ago
|
Insider Cluster
| $3.55 $4.23 | ▼ −19.15% | ▼ −15.97% | $4.16 (−17.18%) |
|
Mar 12, 2026
13w ago
|
8-K
| $3.90 $3.59 | ▼ −7.95% | ▼ −6.97% | $4.16 (+6.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access